Abstract

Common pathological features of amyotrophic lateral sclerosis (ALS) include cytoplasmic aggregation of several RNA-binding proteins. Out of these RNA-binding proteins, TDP-43, FUS/TLS and RGNEF have been shown to co-aggregate with one another within motor neurons of sporadic ALS (sALS) patients, suggesting that there may be a common regulatory network disrupted. MiRNAs have been a recent focus in ALS research as they have been identified to be globally down-regulated in the spinal cord of ALS patients. The objective of this study was to identify if there are miRNA(s) dysregulated in sALS that are responsible for regulating the TDP-43, FUS/TLS and RGNEF network. In this study, we identify miR-194 and miR-b2122 to be significantly down-regulated in sALS patients, and were predicted to regulate TARDBP, FUS/TLS and RGNEF expression. Reporter gene assays and RT-qPCR revealed that miR-b2122 down-regulates the reporter gene through direct interactions with either the TARDBP, FUS/TLS, or RGNEF 3’UTR, while miR-194 down-regulates firefly expression when it contained either the TARDBP or FUS/TLS 3’UTR. Further, we showed that miR-b2122 regulates endogenous expression of all three of these genes in a neuronal-derived cell line. Also, an ALS-associated mutation in the FUS/TLS 3’UTR ablates the ability of miR-b2122 to regulate reporter gene linked to FUS/TLS 3’UTR, and sALS samples which showed a down-regulation in miR-b2122 also showed an increase in FUS/TLS protein expression. Overall, we have identified a novel miRNA that is down-regulated in sALS that appears to be a central regulator of disease-related RNA-binding proteins, and thus its dysregulation likely contributes to TDP-43, FUS/TLS and RGNEF pathogenesis in sALS.

Highlights

  • Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegenerative disease resulting in paralysis and death within 2–5 years after diagnosis [1, 2]. 5–10% of ALS cases are familial, while the remaining are sporadic ~10–12% of these latter cases have a genetic basis [1, 3, 4]

  • Our results suggest that the down-regulation of miR-b2122 within sporadic ALS (sALS) cases could result in altered levels of all three of these RNA-binding proteins, contributing to the pathological state of TAR DNA-binding protein (TDP-43), FUS and Rho guanine nucleotide exchange factor (RGNEF) observed within motor neurons of sALS patients

  • It has been previously shown that the pathogenesis of sALS likely does not rely on the dysregulation of a single RNA-binding protein, but a combination of TDP-43, Fused in sarcoma/translocation in liposarcoma (FUS/TLS) and RGNEF, as they co-aggregate with each other in motor neurons of sALS patients [6]

Read more

Summary

Introduction

Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegenerative disease resulting in paralysis and death within 2–5 years after diagnosis [1, 2]. 5–10% of ALS cases are familial (fALS), while the remaining are sporadic (sALS) ~10–12% of these latter cases have a genetic basis [1, 3, 4]. It has been shown that miRNAs, essential regulators of mRNA expression and protein synthesis, are globally down-regulated within the spinal cord tissue of sALS patients [13, 14] This down-regulation of miRNA expression has been shown to be motor neuron specific [15], contributing to the concept that altered miRNA homeostasis is a major contributor to the pathogenesis of ALS [16, 17]. The finding of this global down-regulation of miRNAs within sALS patients is intriguing, as TDP-43 and FUS/TLS, two proteins often found to be dysregulated in sALS, are known to be essential components of miRNA biogenesis [18, 19]. This suggests that there may be a disruption in the feedback networks between miRNAs and RNA-binding proteins in ALS, including TDP-43 and FUS/TLS

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.